USPTO serial 79099607
VIVALIS
Reviewed by CopyMark Law Group
Reg. 4243981Status 404
- Filing date
- Status date
- Registration date
- Nov 20, 2012
- Examiner
- RICHARDS, LESLIE
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VIVALIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Molecules obtained from biotechnologies, proteins, and biotechnological products for research and diagnosis; proteins in raw material form for scientific and medical research; micro-organisms, namely, cultures of microorganisms other than for medical and veterinary use; cells, avian embryonic stem cells, cell lines, viruses, nucleotides, plasmids, DNA or RNA sequences, vectors for research and diagnosis, all these products being not for medical or veterinary purposes; biological preparations for use in cell cultures other than for medical or veterinary purposes; bacteriological preparations for use in cell cultures other than for medical and veterinary use | SECTION 18 - CANCELLED | — |
| 005 | Prophylactic and therapeutic medicines, pharmaceutical and veterinary products, namely, medical, biological, biotechnological and/or genetic technology preparations and products for medical, pharmaceutical or veterinary use for use in the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; micro-organisms, cells, cell lines, viruses, nucleotides, plasmids, DNA or RNA sequences, vectors for therapy and diagnosis, all for medical use; molecules and antibodies for medical or pharmaceutical use; biotechnological products for medical or pharmaceutical use, namely, for use in the treatment of autoimmune diseases, inflammation, cancer, infectious diseases, diseases of the central nervous system, cardiovascular diseases, neurodegenerative and chronic diseases; diagnosis products for medical or pharmaceutical use, namely, prophylactic and therapeutic vaccines, * none relating to sexual health * | SECTION 18 - CANCELLED | — |
| 042 | Scientific services, namely, scientific research; research and development of new products or process for production and/or purification of biological products for third parties, biological research and research in the fields of bacteriology, virology, immunology, biotechnology, genetics, medicine, pharmacology, and scientific research services for medical purposes; scientific research services for pharmaceutical purposes and scientific research services for veterinary purposes; development of technologies and scientific and industrial research to obtain and prepare cells, cell lines, and to produce and/or purify proteins, viruses, human and animal material | SECTION 18 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Dec 11, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Sep 26, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 23, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 24, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 2, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 2, 2015 | INPC | INVALIDATION PROCESSED | — |
| Apr 25, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 25, 2014 | C18. | CANCELLED SECTION 18-TOTAL | — |
| Aug 25, 2014 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Aug 15, 2014 | CANG | CANCELLATION GRANTED NO. 999999 | — |
| May 22, 2014 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Mar 28, 2014 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Aug 18, 2013 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 25, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 6, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 6, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 6, 2013 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 2, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 20, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 4, 2013 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 18, 2012 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Dec 18, 2012 | PLGL | ASSIGNED TO PARALEGAL | — |
| Dec 18, 2012 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Dec 1, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 20, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 24, 2012 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 12, 2012 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Sep 14, 2012 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 27, 2012 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 8, 2012 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 29, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 29, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 16, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 16, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 9, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 23, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 21, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 23, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 23, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 12, 2012 | ALIE | ASSIGNED TO LIE | — |
| Feb 22, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 1, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 18, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 31, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 31, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 31, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 30, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 26, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 2, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 27, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 22, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |